CLIENT NEWS
- Marinomed Biotech AG signs new agreement for Carragelose in South Korea12 April 2022
- RedHill Reports Potent Inhibition of Omicron with Oral COVID-19 Drug Candidate Opaganib In Vitro11 April 2022
- PEI Regulatory Approval Received for Government Funded (€ 7.4 Million) Clinical Trial Investigating Adrenomed’s Adrecizumab in Treating Endothelial Barrier Dysfunction in Hospitalized COVID-19 Patients11 April 2022
- MagForce AG: MagForce USA, Inc. receives Payment Code Approval by the American Medical Association for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System08 April 2022
- AiCuris nominates Madam Therapeutics with its innovative peptide approach to fight AMR as the first winner of the AiCubator Resident Status in 2022 at BIOCOM AMR Conference 202208 April 2022
- Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer07 April 2022
- iOmx to Present New Pre-Clinical Data on SIK3 Checkpoint Inhibitor OMX-0407 at AACR 202207 April 2022
- Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis06 April 2022
- ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target06 April 2022
- Newron announces AGM 2022 results05 April 2022